Horton, J <br/><br/>
Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.  [electronic resource] 

 -  Cancer chemotherapy reports   
 - 333-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0069-0112 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Colonic Neoplasms--drug therapy<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Humans<br/>Lomustine--adverse effects<br/>Neoplasm Metastasis<br/>Nitrosourea Compounds--therapeutic use<br/>Procarbazine--adverse effects<br/>Streptozocin--adverse effects<br/>Thioguanine--adverse effects